TransCode Therapeutics's market cap is currently ―. The company's EPS TTM is $-472.874; its P/E ratio is >-0.01; TransCode Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -4.34M	$ -4.90M	$ -5.53M	$ -4.29M	$ -4.67M
EBITDA	-	$ -4.80M	$ -5.50M	$ -4.26M	$ -4.65M
Net Income Common Stockholders	$ -4.34M	$ -4.82M	$ -5.13M	$ -4.29M	$ -4.67M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.60M	$ 1.60M	$ 5.00M	$ 8.79M	$ 13.44M
Total Assets	$ 5.88M	$ 5.59M	$ 7.59M	$ 12.02M	$ 14.16M
Total Debt	$ 663.29K	$ 768.23K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -2.94M	$ -831.77K	$ -5.00M	$ -8.79M	$ -13.44M
Total Liabilities	$ 3.79M	$ 5.83M	$ 4.35M	$ 3.77M	$ 1.73M
Stockholders Equity	$ 2.09M	$ -236.79K	$ 3.24M	$ 8.24M	$ 12.43M
Cash Flow	-
Free Cash Flow	-	$ -4.53M	$ -4.13M	$ -4.42M	$ -3.41M
Operating Cash Flow	$ -4.40M	$ -4.51M	$ -4.10M	$ -4.42M	$ -3.37M
Investing Cash Flow	$ -18.11K	$ -12.90K	$ -28.21K	$ 0.00	$ -42.05K
Financing Cash Flow	$ 6.36M	$ 1.18M	$ 225.82K	$ -225.82K	$ 0.00

Currency in USD

TransCode Therapeutics Earnings and Revenue History

Income Statement >

TransCode Therapeutics Debt to Assets

Balance Sheet >

TransCode Therapeutics Cash Flow

Cash Flow >

TransCode Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing